Bryant, Helen E.

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature

PARP inhibition in cancer therapyDNA Repair Mechanisms

Cited by 5,198

PI3King the Lock: Targeting the PI3K/Akt/mTOR Pathway as a Novel Therapeutic Strategy in Neuroblastoma

King, D., Yeomanson, D., & Bryant, H. E. (2015) · Journal of Pediatric Hematology/Oncology

Neuroblastoma Research and TreatmentsPI3K/AKT/mTOR signaling in cancer

Cited by 248